Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0001477449-24-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-08-30 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | — | +7,803 | 49.1K | +19% | — |
| D | 2024-09-04 | 2024-09-03 | TDOC | Vandervoort Adam C | CLO, Sec | S - Sale+OE | $7.16 | -2,817 | 46.2K | -6% | -$20.2K |
| DM | 2024-09-04 | 2024-08-30 | TDOC | Vandervoort Adam C | CLO, Sec | M - OptEx | $0.00 | -7,803 | 26.5K | -23% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | M | A | 1,881 | — | 44,650 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-08-30 | M | A | 1,505 | — | 42,769 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-09-03 | S | D | 2,817 | $7.16 | 46,250 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 4 | Common | Common Stock | 2024-08-30 | M | A | 4,417 | — | 49,067 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 5 | Derivative | Restricted Stock Units | 2024-08-30 | M | D | 1,881 | $0.00 | 3,762 | D | — · — to — | 1,881 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 6 | Derivative | Performance Stock Units | 2024-08-30 | M | D | 1,505 | $0.00 | 9,035 | D | — · — to — | 1,505 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F4) The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Restricted Stock Units | 2024-08-30 | M | D | 4,417 | $0.00 | 26,508 | D | — · — to — | 4,417 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F6) On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |